Which of the following DPP IV inhibitors does not require dose modification in Chronic kidney disease patients
High-Yield Explanation
Linagliptin is is DPP IV inhibitors does not require dose modifications in Chronic kidney disease patients and can be used even in stage 5 ckd patients .